Covered recipient · General Payments record
SHEEJA FRANCIS
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$28,779.50
- Reported across 234 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,160.00 | 1 |
| Travel and Lodging | $1,478.67 | 1 |
| Food and Beverage | $1,153.94 | 49 |
| Education | $77.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $3,961.07 | 7 |
| ABBVIE INC. | $89.90 | 5 |
| Acerta Pharma LLC | $67.72 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $64.92 | 4 |
| Sumitomo Pharma America, Inc. | $57.45 | 3 |
| E.R. Squibb & Sons, L.L.C. | $55.44 | 2 |
| GlaxoSmithKline, LLC. | $52.27 | 3 |
| GENZYME CORPORATION | $46.30 | 2 |
| Lilly USA, LLC | $43.16 | 2 |
| Amgen Inc. | $42.24 | 2 |
| PROGENICS PHARMACEUTICALS, INC. | $38.44 | 2 |
| Antares Pharma, Inc. | $31.24 | 2 |
| ANI Pharmaceuticals, Inc. | $30.25 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $24.44 | 1 |
| UROGEN PHARMA, INC. | $24.22 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $23.71 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.08 | 1 |
| PFIZER INC. | $23.06 | 1 |
| Celltrion USA Inc. | $22.29 | 1 |
| PROCEPT BioRobotics Corporation | $21.54 | 1 |
| UCB, Inc. | $20.95 | 1 |
| 180 Medical, Inc. | $20.92 | 1 |
| Myriad Genetic Laboratories, Inc. | $20.18 | 1 |
| Kiniksa Pharmaceuticals International, plc | $20.03 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.32 | 1 |
| COLOPLAST CORP | $15.03 | 1 |
| Medtronic, Inc. | $14.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.